Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Exploratory, Multicenter, Open-Label Trial to Determine the Safety and Preliminary Clinical Activity of GEN1046 in Combination With Anticancer Agents in Subjects With Advanced Endometrial Cancer

NCT06046274 is registered in ClinicalTrials.gov with Genmab as lead sponsor.

NCT NCT06046274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06046274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Exploratory, Multicenter, Open-Label Trial to Determine the Safety and Preliminary Clinical Activity of GEN1046 in Combination With Anticancer Agents in Subjects With Advanced Endometrial Cancer
Lead sponsor
Genmab
Phase
Phase 2
Overall status
Withdrawn
Start date
October 1, 2023
Completion date
June 1, 2028
Enrollment
0 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

advanced endometrial cancer